chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, Myalgia, Chills, swelling at the site which feels hard to touch (approximately 4 inches in diameter) Narrative:
Headache,  Sore in upper left arm,  Fatigue,  Chills
Heart palpitations, arrhythmia, hypotension,  lung inflammation, bowel inflammation, excess urination, difficulty swallowing, insomnia, nerve pain, swelling of hands and face
high blood pressure; cholesterol; flutter; her hands were red and felt warm; heart pains; she wakes up groggy; pain in middle of her chest; she felt tired/she feels worse; her arm hurt; her hands were red and felt warm; her legs felt heavy; This is a spontaneous report received from a contactable consumer, the patient. A 79-years-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration, administered in Arm Left on 04Mar2021 at 17:15 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included blood cholesterol increased from 2011 and ongoing; diagnosed 10 years ago, hypertension from 1991 and ongoing; diagnosed 30 years ago, chest pain from an unknown date and unknown if ongoing. Concomitant medications included atenolol taken for blood pressure from an unspecified start date and ongoing; benazepril hydrochloride, hydrochlorothiazide taken for blood pressure from an unspecified start date and ongoing; nifedipine taken for blood pressure from an unspecified start date and ongoing; simvastatin taken for blood cholesterol increased from an unspecified start date and ongoing. The patient experienced she was having issues with her heart/she also has pain in middle of her chest like heart pains/seems like more pressure and sort of constant, her hands were red and felt warm, high blood pressure, cholesterol, flutter, her legs felt heavy on 04Mar2021, she felt tired/she feels worse on 06Mar2021, she wakes up groggy, her arm hurt on 04Mar2021, she was having issues with her heart/she also has pain in middle of her chest like heart pains/seems like more pressure and sort of constant. Her hands were red and felt warm, had high blood pressure, cholesterol, flutter, her legs felt heavy, she felt tired/she feels worse, she wakes up groggy, and her arm hurt. She states that she could hardly sleep on the left side, so she is going to have it on the right next. The chest pains started a few weeks ago and it started before the vaccine but now it seems like more pressure and sort of constant, not a pain, pain but a pressure that she knows is there. Now and then she feels a flutter. Clinical outcome of heart pain was not recovered, for hands were red and felt warm, high blood pressure, cholesterol, flutter, she felt tired, she wakes up groggy, pain in middle of her chest was unknown, her legs felt heavy, her arm hurt was recovered.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
3 days post vax for smallpox, experienced moderate swelling of face and hands w/tingling of arm opposite vax site.
Patient developed rash on both hands a few days after receiving vaccine. Rash still present after 2 weeks. No other issues. Rash was red, raised welts.
Partial Cranial Nerve 3 Palsy, right side Symptom: Diplopia, Ptosis
REDNESS AND SWELLING AROUND INJECTION SITE FOR 5 TO 7 DAYS AFTER ADMINISTRATION
This spontaneous report as received from a registered pharmacist via field representative, refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with PNEUMOVAX23 injection (dose, route and lot number were not reported). Other suspect therapies included influenza virus vaccine (manufacturer unknown) (dose, route, date of administration and lot number were not provided).  No concomitant medications were reported. On an unknown date, the patient experienced vomiting and had swelling at the injection site. The patient did not seek medical attention. The outcome of swelling at the injection site and vomiting was unknown.  Additional information has been requested.
Starting early February about 2 weeks after vaccine administration pt began having intermittent headaches and jaw pain, which progressed to rapid and complete painless vision loss 4/20/21 to right eye. Seen same day in ophthalmology clinic, diagnosed with optic nerve ischemia, likely GCA, Rx'd 80mg PO prednisone, lab evaluation started which revealed elevated CRP. This, in combination new new grey 'veil' over vision of L eye the next day 4/21/21, led to admission and initiation of 1,000mg daily IV methylprednisolone. Unfortunately pt then progressed to complete painless loss of vision of left eye as well on 4/23/21 while inpatient on high dose steroids. Patient is now completely blind in both eyes.
A few days after my vaccine I started experiencing heavy  menstraul bleeding. I also started having irregular periods.  About a month later I started experiencing abdominal pain and fatigue.  I ended up going to the ER and they found a softball sized fibroid. I ended up having to save it surgically removed abdominally and have a hysterectomy. The doctor says that the fibroid was not a ?normal consistency?. Instead of being hard or fell apart like tissue paper when they tried to remove it. I know the fibroid wasn?t there in April when I got my annual exam. I also had a abdominal CT in September of 2020 that showed no abnormalities.
First dose vaccine 2/22/2021 2nd dose 3/27/2021 local pop up tent location . On May 18, 2021 I had double vision in the am. It got progressively worse. 3 months later 8/5/2021 diagnosed with Ocular Mysasthenia Gravis.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), PYREXIA (Fever - Temperature of 101.9F), HEADACHE (Headache) and FATIGUE (Fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 030A21A) for COVID-19 vaccination.  Concomitant products included METOPROLOL, LEVOTHYROXINE, ESCITALOPRAM and OMEPRAZOLE for an unknown indication. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN (Pain), PYREXIA (Fever - Temperature of 101.9F), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, PAIN (Pain), PYREXIA (Fever - Temperature of 101.9F), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 101.9 (Inconclusive) Temperature of 101.9F. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.
Chills, aching body, sweating, nausea, upset stomach/vomiting, dizziness, loud static ringing in ears while dizzy/vomiting, injection site soreness. Vomiting subsided but other side effects remain in the afternoon the day after vaccination.
Feeling bad like how I feel when I get a cold; Not feeling quite as peppy; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSED MOOD (Not feeling quite as peppy) and FEELING ABNORMAL (Feeling bad like how I feel when I get a cold) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced DEPRESSED MOOD (Not feeling quite as peppy). On 23-Jan-2021, the patient experienced FEELING ABNORMAL (Feeling bad like how I feel when I get a cold). On 23-Jan-2021, DEPRESSED MOOD (Not feeling quite as peppy) and FEELING ABNORMAL (Feeling bad like how I feel when I get a cold) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Immune system was repressed because of vasculitis and the medicines that taken for that. No treatment medication were provided.  The patient received his first dose of the vaccine at 5:00 PM and around 10:00 PM that day he was "not feeling quite as peppy and slept well most of that evening and woke up feeling bad like how he feel when he get a cold.He felt completely improved by noon.
Patient had a gout attack in his right foot; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Patient had a gout attack in his right foot) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Gout (had gout 6 months ago).    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced GOUT (Patient had a gout attack in his right foot). At the time of the report, GOUT (Patient had a gout attack in his right foot) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment was reported as unspecified gout medicine.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Event outcome updated.
14 x 13 cm area of erythema, warmth, and tenderness at the injection site, lasted x 4-5 days, resolved with Benadryl. Pt was also limping.
Information has been received from a physician concerning an 8 year old patient who on 11-AUG-2001 was vaccinated with the first dose of VARIVAX (Oka/Merck). On 22-JAN-2009, the patient developed chicken pox on face, lips and arms. The patient sought unspecified medical attention. Additional information has been requested. Follow-up information was received from a physician. It was reported that the 8 year old female (birth weight 4 lbs 1 oz, now 54 lbs 8 oz) with no illness at time of vaccination or pre-existing allergies, birth defects or medical conditions was vaccinated SQ with the first dose of VARIVAX (Merck) (lot #: 638250/0467L) into left thigh on 11-AUG-2001. On 20-JAN-2009, at 10:20, the patient developed several red regular lesions after exposure to varicella at school. ON 22-JAN-2009, the patient was seen in office. At the time of this report, the patient was recovered. No further information is available.
The pt experienced joint pain in the left elbow and left knee. Beginning in 7/00 and still occurring. It varies in intensity, sometimes can not ever pick up a gallon of milk.
Information has been received from a certified medical assistant concerning a 56 year old female with drug hypersensitivity to codeine who on 26-SEP-2007 was vaccinated IM, into the left arm, with a 0.5 ml dose of PNEUMOVAX 23 (lot#655765/0061U). Concomitant therapy included CELEBREX, hydrochlorothiazide, LEXAPRO, XANAX, atenolol and TEKTURNA. On 02-OCT-2007 the patient developed skin lesions at the injection site on the left arm. The area was "quarter sized" and described as an open area with green and yellow drainage. She was seen in the physicians office on 11-OCT-2007 and 23-OCT-2007. The patient was initially treated with KEFLEX. At the time of the report, the patient the area was about the size of a dime and the patient was bring treated with LEVAQUIN. It was reported that the physician would like to be contacted if this was a "bad lot." A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
A report was received from a health care professional on 12/8/03 concerning an 18 month old male vaccinee who inadvertently received Fluvirin on the same day. On 12/8/03 the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up received 6/1/04, no adverse experience reported.
Onset was around 6/18/21. He went to the hospital on 6/23 and was admitted. He was discharged on 6/25 and went back to the hospital on 6/26 and was there until 7/1. He still has muscle/body aches, headaches, a sore throat, loss of taste and smell, fatigue and shortness of breath. He currently is using supplemental oxygen. Patient has lupus and COPD. He said he has had several heart attacks in the past. Patient doesn't know where he was exposed.
Patient presented to pharmacy with appointment for COVID-19 vaccine.  She stated she had received her first dose in a hospital in January but they did not give her a record card to show what she received.  At administration, pharmacist stated he was giving the patient the Moderna COVID-19 vaccine.  After administering the vaccine, the patient stated she had received the Pfizer vaccine at the hospital. Pharmacist did not specifically ask the patient what vaccine she received first nor did he check or  systems to verify the first dose before administering.  In STC database, the type of vaccine (Pfizer) was not noted for the one the patient received on January 2,2021 but it did have Pfizer when was accessed.
Info has been received from a registered nurse concerning a 67-year-old female with no known allergies, type II diabetes mellitus, and hypertension who on 06/07/2002 at 5:00 PM was vaccinated IM in the left deltoid with a 2nd dose of pneumococcal vaccine 23 polyvalent (lot #641532/1353L). On 06/07/2002 (also reported as 06/10/2002) at 5:00 PM the pt developed pain and redness in the left arm 4" above the elbow to 2" below the elbow medially reddened, mildly indurated and warm which extended to the posterior triceps area. There was no fever. The vial was cultured and showed no growth. The event required a doctor visit. It was noted that a 1st dose of pneumococcal vaccine 23 polyvalent was given in 1993 and that on return visits for other reasons there were no complaints of problems with the left arm. The pt recovered on 07/01/2002. No further info is requested.
SO SICK; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. The company is unable to perform follow up to request batch number. On an unspecified date, the subject experienced so sick. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of so sick was not reported. This report was non-serious.
PATIENT STATES SHE DEVELOPED HIVES, SHORTNESS OF BREATH. SHE WENT TO THE HOSPITAL ON 07/29/2018 AND WAS TOLD SHE WAS HAVING AN ALLERGIC REACTION TO SHINGRIX. RECEIVED WRITTEN PRESCRIPTIONS FOR RANTIDINE 150MG, PREDNISONE 20MG, AND TRIAMCINOLONE 0.1% CREAM FOR REACTION.
Painful, pruritic and migrating rash, size goes from half cm to 2 cm, started 4 days after the shot, and it is still going on. the rash appears anywhere in the body including the soles ( heals and it is very painful), it lasts few hours to one day and goes away. It is most of the time accompanied with arthralgia and headaches.
This spontaneous report as received from a physician and from a support services director via two company representatives refers to a patient of unknown age and gender. No information regarding the patient's medical history and concurrent conditions was provided. On 05-DEC-2014, the patient was vaccinated with an improperly stored RECOMBIVAX HB 10 Pk 10mcg/1ml SD LLok w Cap AD (lot # K008988, expiry date 04-FEB-2016; dose and route of administration were not reported). There were no concomitant therapies reported. The dose of the vaccine was exposed to two separate temperature excursion (dates unspecified): one lasting for 144 hours, with the lowest recorded temperature of 31 degrees Fahrenheit (-0.55 degrees Celsius and the second one lasting for 48 hours, with the lowest recorded temperature of 34 degrees Fahrenheit (1.11 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
pt devel flu-like sx including fever 101, cough, & difficulty breathing approx 1 & 1/2 months p/flu vax; tx Ceclor;
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-426305 (Patient Link).
A nurse reported that a 3 month old male received an injection of Prevnar on 9/11/00. Within 24 hours, post vax, he developed a generalized body rash, experienced lethargy and irritability. He recovered within the next 24 hours. Additional information received from the reporter on 10/30/00, stated that, post vax, the infant developed a fever greater than 101F. The reporter provided additional pt identifiers. The infant remained recovered.
diarrhea, vomiting, off and on fevers, dizzy, equilibrium issues, day dreaming, falling, bruising extremely easy, liver damage
pt recvd vax 26JUL93 & devel a rash around her eyes & swollen eyes; pt recovered on 9AUG93;
tested positive for Covid; tested positive for Covid; sore arm; This is a spontaneous report from contactable nurses. This nurse reported similar events for two patients. This case is serious. The other case is non-serious.  An adult female patient (of an unspecified age) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm (upper arm deltoid) on 02Apr2021 15:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included obesity, and exposure to COVID from 03Apr2021 to 04Apr2021. The patient was not a smoker/former smoker. The patient's concomitant medications were not reported. The patient received the first dose of the vaccine on 02Apr2021. Over Easter (the weekend of the 4th, on 03Apr2021 and 04Apr2021), she was exposed to the virus by her sister. She took a test 2 to 3 days after exposure but it was negative. The patient did not have symptoms, just a sore arm on an unspecified date in Apr2021. Then this past Monday she woke up feeling really bad and said she felt like she got hit by a truck. It was when the patient started feeling bad that the doctor said to go get tested. The patient tested positive for COVID on 19Apr2021. The patient has been out all week. Clinical signs included a cough and sore throat. The patient was not hospitalized. The patient did not require supplemental oxygen. Therapeutic measures were taken as a result of the event cough. She only took something for her cough, cough syrup (Phenargran and promethazine is the generic version). No additional treatments. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative on Apr2021, SARS-CoV-2 test: positive on 19Apr2021. The outcome of the event sore arm was recovered on an unspecified date while for other events was recovering. The events were considered as serious (medically significant). The patient is due for her next vaccine on 23Apr2021 and wants to know if she should get that vaccine. No history of all previous immunization with the Pfizer vaccine considered as suspect. The patient just went to urgent care when she was not feeling well. No other vaccinations within four weeks prior to the first administration date of the suspect vaccine.  Information about lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2  on reported events cannot be excluded in a context of LOE.,Linked Report(s) : US-PFIZER INC-2021461201 same reporter, different patients, similar events
Information has been received from a Licensed Practical Nurse concerning a 12 year old male patient who on 29-JUL-2010 was vaccinated with his second dose of VARIVAX (Merck) (Lot# unknown). Concomitant therapy included ADACEL, VAQTA (MSD) and MENACTRA. The nurse reported that on 29-JUL-2010, the patient had an atypical VARIVAX (Merck) reaction. The patient had an impressive rash everywhere that looked horrible. On an unspecified date, the patient went to the hospital but was not admitted. The patient went to a dermatologist on 30-JUL-2010 and the dermatologist believed the rash was due to VARIVAX (Merck). The rash had not changed. Patient was placed on VALTREX and XYZAL. At the time of the report, the patient had not recovered. Follow-up information has been received from a Licensed Practical Nurse concerning the male patient with no illness at time of vaccination who on 29-JUL-2010 (also reported as 28-JUL-2010) was vaccinated intramuscularly with his second dose of VARIVAX (Merck) (Lot# 666872/0473Z). Concomitant therapy administered intramuscularly included a first dose of ADACEL (lot number 3382AA) and MENACTRA (lot number 43068A7). Suspect therapy given included a first dose of VAQTA (MSD) (lot number 668349/0795Z). On 30-JUL-2010 (previously reported as 29-JUL-2010) the patient had a rash which was diagnosed as atypical VARIVAX (Merck) reaction. On an unspecified date, the patient recovered from rash. Additional information is not expected.
Patient experienced lymphadenopathy in the supraclavicular and axillary lymph nodes as well as generalized malaise and arthralgias.
2 hours later, full body "heat" and flushing. Lasted 2.5 days. Many fruits do this. No reaction with second dose.